Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [8]. Core Insights - The company reported a revenue of 7.228 billion yuan in Q1 2025, reflecting a year-on-year increase of 4.94% and a quarter-on-quarter increase of 13.90%. However, the net profit attributable to shareholders was 311 million yuan, showing a year-on-year decline of 18.61% but a quarter-on-quarter increase of 8.19% [1]. - A new phosphate mining project with an annual capacity of 4 million tons is expected to commence production in 2025, which will serve as a new profit growth point for the company [2]. - The company is focusing on enhancing shareholder returns, with a cash dividend of 1 yuan per share for 2024, resulting in a dividend yield of 4.61% [4]. - The company has a strong market position in yellow phosphorus production, with an annual capacity exceeding 160,000 tons, and is advancing in the commercialization of black phosphorus products [2]. - The company is also managing its market value effectively, with its second-largest shareholder planning to increase holdings by 220 million to 440 million yuan [2]. Financial Summary - The company’s sales expense ratio for Q1 2025 was 0.79%, a decrease of 0.32 percentage points year-on-year and 0.90 percentage points quarter-on-quarter. The management expense ratio was 4.35%, showing a slight increase of 0.05 percentage points year-on-year but a decrease of 4.48 percentage points quarter-on-quarter. The financial expense ratio was 1.38%, up 0.09 percentage points year-on-year and 0.20 percentage points quarter-on-quarter. The R&D expense ratio was 3.05%, down 0.03 percentage points year-on-year and 2.36 percentage points quarter-on-quarter [3]. - The company forecasts net profits attributable to shareholders of 1.628 billion yuan in 2025, 1.867 billion yuan in 2026, and 2.138 billion yuan in 2027, with corresponding price-to-earnings ratios of 14.0, 12.2, and 10.7 times [8].

Investment Rating - The report maintains a "Buy" rating for the company [1][8] Core Insights - The company focuses on electronic vacuum devices and military semiconductor sectors, driving strong performance growth [1] - The company has a diverse product range that is widely used in various fields including new energy vehicles, aerospace, military, photovoltaic, and semiconductor equipment manufacturing [4] - In 2024, the company achieved a revenue of 792 million yuan, a year-on-year increase of 14.46%, while net profit decreased by 52.89% [5] - The company is positioned to benefit from the domestic substitution trend, with expectations for a performance inflection point in 2025 [4] Revenue and Profit Forecast - The company forecasts revenues of 1.28 billion yuan, 1.65 billion yuan, and 1.998 billion yuan for 2025, 2026, and 2027 respectively, with corresponding EPS of 1.38 yuan, 2.26 yuan, and 3.16 yuan [8][10] - The projected revenue growth rates are 61.5% for 2025, 28.5% for 2026, and 21.4% for 2027 [10] Business Segments Performance - In 2024, the revenue from vacuum relays (military) was 120 million yuan with a gross margin of 62.47% [4] - The revenue from DC contactors (new energy vehicles) was 413 million yuan, a year-on-year increase of 28.29%, with a gross margin of 19.50% [4] - The revenue from vacuum capacitors (semiconductors) was 73 million yuan, a year-on-year increase of 81.18%, with a gross margin of 41.88% [4] Market Position and Competitive Advantage - The company has established itself as a key supplier in the military electronic vacuum device market, with a strong customer retention due to high entry barriers [6] - The company has made significant technological advancements, including the development of high-voltage control boxes and high-power DC intelligent distribution systems [6][7] - The company is expanding its presence in the semiconductor equipment manufacturing sector, with products that are competitive in performance and pricing compared to foreign brands [7] Strategic Partnerships and Market Expansion - The company is collaborating with major semiconductor manufacturers like Huawei, with expectations for increased product supply in 2024 [7] - The company is also expanding its overseas market presence through its Singapore subsidiary, enhancing its global influence [7]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][4]. Core Views - The domestic market is poised for recovery, and overseas business is performing strongly. The company is expected to benefit from the gradual recovery of procurement in 2025, leading to a turning point in domestic operations [4][5]. - The company has implemented an active dividend policy, with dividend payouts of 679 million and 1.71 billion for 2024 and 2025 respectively, reflecting a payout ratio of 6% and 65% [5]. - Revenue for 2024 is projected at 36.726 billion (up 5.14%), with net profit attributable to the parent company at 11.668 billion (up 0.74%). For Q1 2025, revenue is expected to be 8.237 billion (down 12.12%), with net profit at 2.629 billion (down 16.81%) [5]. - The company is adjusting its profit forecasts for 2025-2027, expecting net profits of 12.913 billion, 14.869 billion, and 17.143 billion respectively, with corresponding EPS of 10.65, 12.26, and 14.14 [5][7]. - The company is transitioning towards a digital and intelligent ecosystem solution provider, integrating technology to address clinical pain points, with a significant increase in revenue contribution from high-end strategic customers [6]. Financial Summary - The company achieved a revenue of 34.932 billion in 2023, with a projected increase to 40.432 billion in 2025, reflecting a year-on-year growth of 10.1% [7]. - The gross margin is expected to remain stable around 63.7% in 2025, while the net margin is projected at 31.9% [7]. - Return on equity (ROE) is forecasted to decline from 34.7% in 2023 to 24.1% in 2025, indicating a potential decrease in profitability [7]. - The company’s P/E ratio is expected to decrease from 23.0 in 2023 to 20.6 in 2025, suggesting a more attractive valuation over time [7].

数通交换机翻倍以上增长，毛利率维稳、业绩高增 公司 2024 年报&2025Q1 业绩点评 本报告导读： 2024 年以来受益国内 AI 发展，公司数据中心交换机全面爆发、收入增速超预期，取 得 200G/400G 数据中心交换机、数据中心交换机互联网行业市场份额第一 投资要点： | [Table_Finance] 财务摘要（百万元） | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 11,542 | 11,699 | 13,837 | 16,095 | 18,136 | | (+/-)% | 1.9% | 1.4% | 18.3% | 16.3% | 12.7% | | 净利润（归母） | 401 | 574 | 771 | 1,012 | 1,200 | | (+/-)% | -27.3% | 43.1% | 34.3% | 31.2% | 18.6% | | 每股净收益（元） | 0.71 | 1.01 | 1.36 | 1.78 | 2.11 | | 净资产收益率(%) | ...

业绩稳健增长，持续推进战略转型 ——九州通 24 年报及 25 年一季报点评 核心观点 ⚫ 盈利预测与投资建议 ⚫ 根据 2024 年报，我们下调收入、毛利率和费用率预测，调整 2025-27 年每股收益预 测分别为 0.54/0.59/0.65（原预测 25-26 年为 0.53/0.58）元，根据可比公司给予 25 年 13 倍 PE，对应的目标价为 7.02 元，维持"买入"评级。 风险提示 医保和药品比价政策风险；应收账款回款不及时风险；行业竞争加剧风险；盈利能力 下滑风险等 | 公司主要财务信息 | | | | | | | --- | --- | --- | --- | --- | --- | | | 2023A | 2024A | 2025E | 2026E | 2027E | | 营业收入(百万元) | 150,140 | 151,810 | 162,732 | 174,346 | 186,714 | | 同比增长 (%) | 6.9% | 1.1% | 7.2% | 7.1% | 7.1% | | 营业利润(百万元) | 3,023 | 3,635 | 3,775 | 4,170 | 4,59 ...

Investment Rating - The report maintains an "Accumulate" rating for the company [1][6]. Core Insights - The company reported significant improvement in Q1 2025 performance, with a net profit increase of over 20 times year-on-year, primarily due to reduced credit impairment losses and lower operating expenses [2][3]. - The company has a strong order reserve, with a total of approximately 383 million yuan in hand orders and bid amounts as of March 2025 [3]. - The company is expanding its services into Douyin's local life virtual live streaming and has undertaken multiple global virtual studio projects, enhancing its market position [4]. - The company has a consistent dividend policy, proposing a cash dividend of 0.20 yuan per 10 shares for 2024, marking 14 consecutive years of cash dividends [5]. Financial Summary - In 2024, the company achieved revenue of 722 million yuan, a year-on-year increase of 9.78%, but reported a net loss of 38.53 million yuan [2][8]. - For Q1 2025, the company generated revenue of 185 million yuan, a 2.72% increase year-on-year, with a net profit of 13.60 million yuan, reflecting a 2139.84% growth [2][3]. - The company expects revenues of 800 million yuan, 920 million yuan, and 1.04 billion yuan for 2025, 2026, and 2027 respectively, with net profits projected at 59 million yuan, 82 million yuan, and 98 million yuan for the same years [6][10].

gzitiao 立足线缆深耕军工，业绩有望持续改善 电网设备 执业证书编号：S0740521080001 Email：chendr01@zts.com.cn 执业证书编号：S0740522020001 Email：zengbiao@zts.com.cn 分析师：马梦泽 执业证书编号：S0740523060003 Email：mamz@zts.com.cn | 总股本(百万股) | 525.74 | | --- | --- | | 流通股本(百万股) | 452.94 | | 市价(元) | 8.39 | | 市值(百万元) | 4,410.95 | | 流通市值(百万元) | 3,800.13 | 相关报告 通达股份（002560.SZ） 证券研究报告/公司点评报告 2025 年 05 月 20 日 | 评级： | 增持（首次） | 公司盈利预测及估值 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 指标 | | 2023A | 2024A | 2025E | 2026E | 2027E | | 分析师：陈 ...

公司研究 证 券 研 究 报 告 国轩高科（002074）2024 年报及 2025 年一季报点评 推荐（维持） 营收增长显著，盈利大幅提升 目标价：29.79 元 事项： 华创证券研究所 ❖ 公司发布的 2024 年年报及 2025 年一季报显示，2024 年公司实现营收 353.92 亿元，同比+11.98%，归母净利润 12.07 亿元，同比+28.56%；扣非后净利润 2.63 亿元，同比+125.86%。2025 年一季度实现营收 90.55 亿元，同比+20.61%； 利润总额达到 0.99 亿元，同比+787.43%；实现归母净利润 1.01 亿元，同比 +45.55%。 评论： | | | | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万) | 35,392 | 43,023 | 52,451 | 64,932 | | 同比增速(%) | 12.0% | 21.6% | 21.9% | 23.8% | | 归母净利润(百万) | 1,207 | 1,358 | 1,790 | 2,657 ...

数据来源：聚源 -36% -24% -12% 0% 12% 24% 2024-05 2024-09 2025-01 迈瑞医疗 沪深300 相关研究报告 医药生物/医疗器械 迈瑞医疗（300760.SZ） 国内市场蓄势待发，海外业务高歌猛进 2025 年 05 月 22 日 投资评级：买入（维持） | 日期 | 2025/5/21 | | --- | --- | | 当前股价(元) | 226.67 | | 一年最高最低(元) | 351.60/206.80 | | 总市值(亿元) | 2,748.24 | | 流通市值(亿元) | 2,748.19 | | 总股本(亿股) | 12.12 | | 流通股本(亿股) | 12.12 | | 近 3 个月换手率(%) | 29.21 | 股价走势图 《高耗+设备整体解决方案落地与数 智化发展可期—公司信息更新报告》 -2024.6.18 Yoy ——公司信息更新报告 | 余汝意（分析师） | 石启正（联系人） | | --- | --- | | yuruyi@kysec.cn | shiqizheng@kysec.cn | | 证书编号：S079052307000 ...

公司报告 | 公司点评 西大门（605155） 证券研究报告 遮阳成品驱动增长 业绩稳健，遮阳成品驱动增长 公司公告 25 年 Q1 实现营收 1.9 亿同比+13%，归母净利润 0.23 亿同比-1%， 扣非归母净利 0.21 亿同比-7%； 24 年公司实现营业收入 8.2 亿元，同比+28%，营收增长主要系公司销售订 单增加；归母净利润 1.2 亿元，同比+34%，扣非归母净利 1.2 亿元，同比 +34%。 公司业绩增速较快，毛利率、净利率进一步提升，盈利能力持续向好。目 前公司在手订单 2-3 个月，基本满产满销，产能可根据订单情况动态调整， 可有效满足客户要求。 分产品看，24 年公司遮阳面料营收 4.7 亿同比-1%，毛利率 38%同比+1.2pct； 遮阳成品营收 3.2 亿同比+120%，毛利率 49%同比+2.0pct；其他产品 0.2 亿同比+48%。 海外市场表现亮眼 分地区看，24 年中国大陆实现营收 1.8 亿同比-13%，中国大陆以外的国家 地区实现营收 6.3 亿同比+48%，中国大陆以外地区收入占比较高且增长较 快。公司通过建立全球销售网络和服务体系，成功拓展了北美、欧洲等主 ...